NexImmune Inc (NEXI)
3.06
+0.05
(+1.66%)
USD |
NASDAQ |
May 31, 16:00
3.02
-0.04
(-1.31%)
After-Hours: 20:00
NexImmune Enterprise Value: -0.2573M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.2573M |
| May 30, 2024 | -0.3258M |
| May 29, 2024 | -0.1888M |
| May 28, 2024 | -0.3122M |
| May 24, 2024 | -0.0914M |
| May 23, 2024 | -0.1629M |
| May 22, 2024 | -0.1202M |
| May 21, 2024 | 0.0717M |
| May 20, 2024 | -0.0517M |
| May 17, 2024 | 0.1211M |
| May 16, 2024 | 0.2637M |
| May 15, 2024 | 0.298M |
| May 14, 2024 | 0.2088M |
| May 13, 2024 | 0.2226M |
| May 10, 2024 | 0.4831M |
| May 09, 2024 | 0.2911M |
| May 08, 2024 | 0.1814M |
| May 07, 2024 | 0.4694M |
| May 06, 2024 | 0.3734M |
| May 03, 2024 | 0.0992M |
| May 02, 2024 | -0.1751M |
| May 01, 2024 | -0.0928M |
| April 30, 2024 | 0.154M |
| April 29, 2024 | 0.0443M |
| April 26, 2024 | 0.1677M |
| Date | Value |
|---|---|
| April 25, 2024 | 0.2226M |
| April 24, 2024 | 0.0169M |
| April 23, 2024 | 0.25M |
| April 22, 2024 | 0.5448M |
| April 19, 2024 | 0.3322M |
| April 18, 2024 | 0.0717M |
| April 17, 2024 | -0.1339M |
| April 16, 2024 | 0.3048M |
| April 15, 2024 | 0.4145M |
| April 12, 2024 | 0.4968M |
| April 11, 2024 | 0.9492M |
| April 10, 2024 | 0.9698M |
| April 09, 2024 | 0.5105M |
| April 08, 2024 | 1.443M |
| April 05, 2024 | 0.6339M |
| April 04, 2024 | 1.827M |
| April 03, 2024 | 2.471M |
| April 02, 2024 | 2.896M |
| April 01, 2024 | 3.198M |
| March 28, 2024 | 3.045M |
| March 27, 2024 | 2.908M |
| March 26, 2024 | 3.155M |
| March 25, 2024 | 3.237M |
| March 22, 2024 | 3.086M |
| March 21, 2024 | 3.402M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-40.93M
Minimum
Mar 11 2022
651.27M
Maximum
Feb 26 2021
60.22M
Average
-6.376M
Median
Nov 17 2023
Enterprise Value Benchmarks
| Mind Medicine Inc | 393.98M |
| Candel Therapeutics Inc | 258.74M |
| Ventyx Biosciences Inc | 35.81M |
| NKGen Biotech Inc | 62.74M |
| CERo Therapeutics Holdings Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.077M |
| Total Expenses (Quarterly) | 2.758M |
| EPS Diluted (Quarterly) | -2.46 |
| Earnings Yield | -787.6% |